Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin versus Prostaglandins for Labor Induction after Unfavorable Cervix
2021-000989-15Phase 3Active
- Sponsor
- CHRU Tours
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of oxytocin in induced labor (2 arms), sponsored by CHRU Tours. Primary endpoint: Caesarean delivery rate. Started Mar 2021; status: active.
02
Drugs
oxytocin
03
Conditions
induced labor
Beyond the preview
Go deeper on 2021-000989-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000989-15.